Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Quarterly Newsletter Release

<< Previous

Bullboard Posts

Next >>

Comment by BuenaSuertaAtodon Feb 25, 2022 10:20am

499 Views

Post# 34461285

RE:Quarterly Newsletter Release

Monday or Tuesday before the open souinds like a good guess as to when the 4Q21 newsletter gets released.

Anyone got a good guess as to what will be in it wro 180 day trial results?

Eoganacht wrote:
4Q20 was released on Feb 01, 2021

1Q21 was released on Apr 27, 2021

2Q21 was released on Aug 30, 2021

3Q21 was released on Nov 29, 2021

The last two quarterly newsletters were released exactly 2 months after the quarter ended.

If Theralase continues this pattern, then the 4Q21 newsletter will be released tomorrow or on Monday.

It`s not likely important news will be released on a Friday so I`m guessing Monday morning or Tuesday before the market opens.

A couple of other posters here have made the same guess. This could be a big one!